drugset / Trial / NCT07300839
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).
Timeline
- Start
- 2025-12-10
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BNT162b2 | Messenger RNA (mRNA) | — | — |